Bilcare Share Price Today (BI)
TODAY IN ONE LINE
BI dropped 3.6%, lagging Nifty's -0.4% move, with no exchange filing today, suggesting a market-driven move.
With a market cap of ₹139.74 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Bilcare flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.03x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 3.3% YoY
- ●Poor Capital ReturnsLow ROE of 1.7%
Latest Bilcare News
What changed recently?
Recent events, corporate actions, and announcements.
Bilcare Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Bilcare Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Bilcare Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Bilcare Ltd — derived from the live tape, not yesterday's close.
Bilcare Ltd last traded at ₹59.27 with an intraday range of ₹59.25–₹60.99 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹59.27| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 63.90 | +4.63 | +7.82% |
| R3 | 62.16 | +2.89 | +4.88% |
| R2 | 61.58 | +2.31 | +3.89% |
| R1 | 60.42 | +1.15 | +1.95% |
| PIVOT | 59.84 | 0.57 | 0.96% |
| CURRENT | 59.27 | — | — |
| S1 | 58.68 | -0.59 | -0.99% |
| S2 | 58.10 | -1.17 | -1.98% |
| S3 | 56.94 | -2.33 | -3.93% |
| S4 | 55.20 | -4.07 | -6.86% |
BI is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹60–₹60
Trading Inside opening range
Bilcare Ltd financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Bilcare Ltd — consolidated or standalone — with margins, YoY growth and key ratios inline.
Bilcare Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹139.74 Cr. and reported EPS of ₹0.73.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 788 | 734 ▼ 6.9% |
| Sales Growth YoY %Derived | 5.47% | -6.92% |
| Other Income | 18 | 30 ▲ 62.5% |
| Total Income | 807 | 764 ▼ 5.3% |
| 534 | 490 ▼ 8.2% | |
| Gross ProfitDerived | 254 | 244 ▼ 4.2% |
| Gross Margin %Derived | 32.27% | 33.21% |
| 210 | 199 ▼ 5.0% | |
| EBITDA (Operating Profit)Derived | 45 | 44 ▼ 0.4% |
| OPM %Derived | 5.66% | 6.06% |
| 122 | 88 ▼ 27.8% | |
| Profit Before Tax (PBT) | -71 | -21 ▲ 69.9% |
| -15 | -4 ▲ 72.5% | |
| Effective Tax %Derived | 21.28% | 19.43% |
| Profit/Loss from Discontinued Ops | — | — |
| Total Profit for Period | -56 | -17 ▲ 69.2% |
| Less: Non-controlling Interests | -27 | -19 ▲ 30.6% |
| Net Profit (Owner's PAT)Derived | -29 | 2 ▲ 106.0% |
| Net Profit Margin %Derived | -3.65% | 0.23% |
| PAT Growth YoY %Derived | 13.39% | 105.98% |
| Earnings Per Share (EPS ₹) | -12.22 | 0.73 ▲ 106.0% |
| Diluted Shares Outstanding (Cr) | 2 | 2 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | -0 | 4 ▲ 1453.8% |
| Total Expenses (incl. D&A & Interest) | 878 | 785 ▼ 10.6% |
| Material Cost % of RevenueDerived | 68.00% | 67.37% |
| Employee Cost % of RevenueDerived | 10.29% | 10.90% |
| Other Cost % of RevenueDerived | 16.32% | 16.26% |
| Interest Coverage (x)Derived | -0.02x | 0.34x |
| Period | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 2,997 | 507 ▼ 83.1% | 623 ▲ 22.8% | 845 ▲ 35.6% | 982 ▲ 16.2% | 747 ▼ 23.9% | 788 ▲ 5.5% | 734 ▼ 6.9% | |
| Sales Growth YoY %Derived | — | -83.08% | 22.81% | 35.65% | 16.20% | -23.88% | 5.47% | -6.92% | |
| Other Income | 60 | 74 ▲ 23.5% | 18 ▼ 75.3% | 15 ▼ 20.7% | 10 ▼ 29.2% | 23 ▲ 118.2% | 18 ▼ 18.0% | 30 ▲ 62.5% | |
| Total Income | 3,057 | 581 ▼ 81.0% | 641 ▲ 10.3% | 859 ▲ 34.0% | 992 ▲ 15.4% | 770 ▼ 22.4% | 807 ▲ 4.8% | 764 ▼ 5.3% | |
1,638 | 340 ▼ 79.2% | 409 ▲ 20.2% | 599 ▲ 46.4% | 704 ▲ 17.5% | 501 ▼ 28.8% | 534 ▲ 6.5% | 490 ▼ 8.2% | ||
| Gross ProfitDerived | 1,359 | 167 ▼ 87.7% | 214 ▲ 28.1% | 246 ▲ 15.0% | 278 ▲ 13.0% | 246 ▼ 11.4% | 254 ▲ 3.3% | 244 ▼ 4.2% | |
| Gross Margin %Derived | 45.35% | 32.90% | 34.33% | 29.10% | 28.29% | 32.94% | 32.27% | 33.21% | |
1,191 | 196 ▼ 83.6% | 163 ▼ 16.7% | 185 ▲ 13.9% | 221 ▲ 19.2% | 207 ▼ 6.4% | 210 ▲ 1.3% | 199 ▼ 5.0% | ||
| EBITDA (Operating Profit)Derived | 168 | -29 ▼ 117.0% | 51 ▲ 277.8% | 60 ▲ 18.6% | 57 ▼ 6.2% | 39 ▼ 30.9% | 45 ▲ 14.0% | 44 ▼ 0.4% | |
| OPM %Derived | 5.62% | -5.65% | 8.18% | 7.15% | 5.77% | 5.24% | 5.66% | 6.06% | |
661 | 325 ▼ 50.9% | 148 ▼ 54.5% | 137 ▼ 7.3% | 325 ▲ 136.8% | 120 ▼ 63.0% | 122 ▲ 1.8% | 88 ▼ 27.8% | ||
| Profit Before Tax (PBT) | -433 | 34 ▲ 107.9% | -25 ▼ 172.8% | -4 ▲ 83.1% | 196 ▲ 4735.5% | -72 ▼ 136.6% | -71 ▲ 0.5% | -21 ▲ 69.9% | |
21 | -22 ▼ 203.4% | -14 ▲ 35.8% | 0 ▲ 100.9% | 146 ▲ 112115.4% | -13 ▼ 109.0% | -15 ▼ 15.3% | -4 ▲ 72.5% | ||
| Effective Tax %Derived | -4.81% | -62.70% | 55.29% | -3.07% | 74.40% | 18.37% | 21.28% | 19.43% | |
| Profit/Loss from Discontinued Ops | — | -155 | — ▲ 100.0% | — | — | — | — | — | |
| Total Profit for Period | -453 | -99 ▲ 78.2% | -11 ▲ 88.7% | -4 ▲ 60.9% | 50 ▲ 1251.4% | -59 ▼ 216.6% | -56 ▲ 4.0% | -17 ▲ 69.2% | |
| Less: Non-controlling Interests | 2 | 5 ▲ 152.0% | 10 ▲ 119.7% | 8 ▼ 17.0% | 35 ▲ 327.2% | -25 ▼ 172.0% | -27 ▼ 8.2% | -19 ▲ 30.6% | |
| Net Profit (Owner's PAT)Derived | -455 | -104 ▲ 77.2% | -21 ▲ 79.7% | -13 ▲ 40.2% | 15 ▲ 219.5% | -33 ▼ 320.9% | -29 ▲ 13.4% | 2 ▲ 106.0% | |
| Net Profit Margin %Derived | -15.19% | -20.42% | -3.38% | -1.49% | 1.53% | -4.45% | -3.65% | 0.23% | |
| PAT Growth YoY %Derived | — | 77.25% | 79.65% | 40.25% | 219.46% | -320.94% | 13.39% | 105.98% | |
| Earnings Per Share (EPS ₹) | -193.29 | -43.97 ▲ 77.3% | -8.95 ▲ 79.6% | -5.35 ▲ 40.2% | 6.39 ▲ 219.4% | -14.11 ▼ 320.8% | -12.22 ▲ 13.4% | 0.73 ▲ 106.0% | |
| Diluted Shares Outstanding (Cr) | 2 | 2 ▲ 0.0% | 2 ▲ 0.0% | 2 ▲ 0.0% | 2 ▲ 0.0% | 2 ▲ 0.0% | 2 ▲ 0.0% | 2 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 2 | 19 ▲ 707.7% | -1 ▼ 104.3% | 2 ▲ 286.4% | 1 ▼ 57.6% | 1 ▲ 40.6% | -0 ▼ 128.9% | 4 ▲ 1453.8% | |
| Total Expenses (incl. D&A & Interest) | 3,490 | 547 ▼ 84.3% | 666 ▲ 21.7% | 864 ▲ 29.6% | 796 ▼ 7.8% | 841 ▲ 5.7% | 878 ▲ 4.3% | 785 ▼ 10.6% | |
| Material Cost % of RevenueDerived | 54.44% | 67.55% | 66.87% | 71.90% | 70.39% | 69.64% | 68.00% | 67.37% | |
| Employee Cost % of RevenueDerived | 20.58% | 10.08% | 8.88% | 7.02% | 6.38% | 9.62% | 10.29% | 10.90% | |
| Other Cost % of RevenueDerived | 19.15% | 28.47% | 17.27% | 14.93% | 16.14% | 18.08% | 16.32% | 16.26% | |
| Interest Coverage (x)Derived | -0.74x | -1.84x | 0.07x | 0.31x | 0.31x | -0.07x | -0.02x | 0.34x |
Bilcare segment analysis : revenue and profit mix.
Disclosed business segments at Bilcare with their share of revenue and profit, switchable between consolidated and standalone reporting.
Bilcare discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Bilcare Ltd.
Our AI distills the core fundamental drivers supporting Bilcare Ltd, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 3.65. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Bilcare Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Bilcare Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Bilcare Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Bilcare Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Bilcare Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Bilcare Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Bilcare Ltd stood at 61.3% of traded volume, against a 20-day average of 70.3%.
Bilcare announcements: results, concalls, ratings, M&A.
Filings Bilcare sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Bilcare files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 32 documents below.
Company Update
Bilcare Limited has submitted the Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the…
Insider Trading / SAST
Bilcare Limited has submitted intimation towards closure of trading window.
Company Update
Bilcare Limited has informed the Exchange about the following: a) Redemption of Preference Shares and b) Conversion of Warrants and Allotment of…
Result
Bilcare Limited has informed the Exchnage that the Board of Directors in their Meeting held on 29 May 2026 have approved Audited Financial Results…
Board Meeting
Bilcare Limited has informed the Exchange about the outcome of Board Meeting held on 29 May 2026
Bilcare dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Bilcare has declared, sequenced by announce and record date.
Bilcare corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Bilcare Ltd: business, sector, key facts.
What Bilcare Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Bilcare Ltd is a listed Indian equity, listed as NSE: BI, BSE: 526853.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- Anlon Healthcare (AHCL) Share PricePeer
- Amanta Healthcare (AMANTA) Share PricePeer
- Top Losers TodayScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Bilcare Ltd (BI).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Bilcare Ltd (BI)?
The current share price of Bilcare Ltd (BI) is ₹59.27. Today, the stock has declined by ₹2.24 (3.64%), trading in a range of ₹59.25 to ₹60.99. The stock opened at ₹60 with a trading volume of 3,990 shares.
02What is the 52-week high and low price of Bilcare Ltd stock?
The 52-week high price of Bilcare Ltd (BI) is ₹75, while the 52-week low is ₹51.62. Currently trading at ₹59.27, the stock is 32.7% away from its 52-week low and 21.0% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
03What is the dividend yield of Bilcare Ltd and when is the next dividend?
Bilcare Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹59.27, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
04How is Bilcare Ltd stock performing today in the market?
Bilcare Ltd stock opened at ₹60 and is currently trading at ₹59.27, showing a decline of ₹2.24 (3.64%). The intraday high is ₹60.99 and low is ₹59.25. The trading volume stands at 3,990 shares, indicating moderate market participation today.
05What is the market capitalization of Bilcare Ltd?
Bilcare Ltd has a market capitalization of ₹139.74 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹59.27) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
06What is the ROE and ROCE of Bilcare Ltd?
Bilcare Ltd has a Return on Equity (ROE) of 1.66% and Return on Capital Employed (ROCE) of 5.56%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
07Which sector and industry does Bilcare Ltd belong to?
Bilcare Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
08What is the debt-to-equity ratio of Bilcare Ltd?
Bilcare Ltd has a debt-to-equity ratio of 3.15, which measures the company's financial leverage by comparing total debt to shareholders' equity. A ratio above 2 indicates high leverage and potentially higher financial risk. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
The data, ratios and commentary about Bilcare Ltd (BI) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.